IFITM2
Basic information
Region (hg38): 11:303655-309397
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IFITM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 1 | 0 |
Variants in IFITM2
This is a list of pathogenic ClinVar variants found in the IFITM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-308214-T-A | not specified | Uncertain significance (Nov 06, 2023) | ||
11-308214-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
11-308242-C-A | not specified | Uncertain significance (Aug 28, 2024) | ||
11-308270-G-C | not specified | Likely benign (Dec 15, 2023) | ||
11-308289-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
11-308295-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
11-308311-C-T | not specified | Uncertain significance (Jan 21, 2025) | ||
11-308315-G-A | not specified | Uncertain significance (Apr 14, 2022) | ||
11-308334-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
11-308340-G-A | not specified | Uncertain significance (Mar 12, 2024) | ||
11-308364-G-A | not specified | Uncertain significance (Jan 18, 2025) | ||
11-308364-G-C | not specified | Uncertain significance (Feb 02, 2025) | ||
11-308391-A-G | not specified | Uncertain significance (Jul 09, 2021) | ||
11-308433-G-A | not specified | Uncertain significance (Apr 24, 2023) | ||
11-309041-T-C | not specified | Uncertain significance (Jun 23, 2023) | ||
11-309053-A-C | not specified | Uncertain significance (Feb 19, 2025) | ||
11-309114-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
11-309133-A-C | not specified | Uncertain significance (Apr 18, 2023) | ||
11-309140-T-A | not specified | Uncertain significance (Jun 17, 2024) | ||
11-309140-T-C | not specified | Uncertain significance (May 08, 2024) | ||
11-309148-G-A | not specified | Uncertain significance (Jan 14, 2025) | ||
11-309148-G-C | not specified | Uncertain significance (Nov 18, 2022) | ||
11-309161-G-A | not specified | Uncertain significance (Feb 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IFITM2 | protein_coding | protein_coding | ENST00000399817 | 2 | 7642 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00515 | 0.481 | 124757 | 0 | 27 | 124784 | 0.000108 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.315 | 89 | 81.0 | 1.10 | 0.00000463 | 868 |
Missense in Polyphen | 9 | 14.692 | 0.61258 | 202 | ||
Synonymous | -1.63 | 47 | 34.8 | 1.35 | 0.00000228 | 261 |
Loss of Function | -0.201 | 3 | 2.65 | 1.13 | 1.15e-7 | 25 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00109 | 0.00109 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000111 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000178 | 0.0000177 |
Middle Eastern | 0.000111 | 0.000111 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. Active against multiple viruses, including influenza A virus, SARS coronavirus (SARS-CoV), Marburg virus (MARV), Ebola virus (EBOV), Dengue virus (DNV), West Nile virus (WNV), human immunodeficiency virus type 1 (HIV-1) and vesicular stomatitis virus (VSV). Can inhibit: influenza virus hemagglutinin protein-mediated viral entry, MARV and EBOV GP1,2-mediated viral entry, SARS-CoV S protein-mediated viral entry and VSV G protein- mediated viral entry. Induces cell cycle arrest and mediates apoptosis by caspase activation and in p53-independent manner. {ECO:0000269|PubMed:19544527, ECO:0000269|PubMed:20064371, ECO:0000269|PubMed:20534863, ECO:0000269|PubMed:20943977, ECO:0000269|PubMed:21177806, ECO:0000269|PubMed:21253575, ECO:0000269|PubMed:22479637}.;
- Pathway
- Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
(Consensus)
Intolerance Scores
- loftool
- 0.437
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.23
Haploinsufficiency Scores
- pHI
- 0.233
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.436
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.614
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ifitm2
- Phenotype
Gene ontology
- Biological process
- immune response;response to virus;response to interferon-gamma;response to interferon-alpha;response to interferon-beta;negative regulation of viral genome replication;negative regulation of viral entry into host cell;defense response to virus;type I interferon signaling pathway
- Cellular component
- plasma membrane;integral component of membrane;protein-containing complex
- Molecular function